Core Viewpoint - Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd. announced its participation in the CICC Medical Fund, focusing on investments in the healthcare sector, particularly in traditional Chinese medicine, biomedicine, medical devices, and related industries [1] Group 1 - The CICC Medical Fund aims to raise a total of 1 billion RMB, with Zhangzhou Pien Tze Huang Investment Management Co., Ltd. committing to invest 200 million RMB, representing 20% of the fund's target size [1] - The fund will primarily invest in projects related to the Pien Tze Huang industry chain, Pien Tze Huang industrial park, and other projects that attract investment to Zhangzhou [1] - The investment strategy aligns with the growing trend in the healthcare sector, emphasizing the importance of traditional Chinese medicine and related health services [1]

Core Viewpoint - The establishment of the CICC (Zhangzhou) Medical Industry Investment Partnership marks a significant investment initiative in the healthcare sector, focusing on traditional Chinese medicine and related industries [1] Group 1: Company Information - CICC (Zhangzhou) Medical Industry Investment Partnership has been established with a total investment of 1 billion RMB, managed by CICC Capital Operation Co., Ltd [1] - The partnership includes contributions from Zhangzhou Gaoxin Development Co., Ltd, Zhangzhou Pien Tze Huang Asset Management Co., Ltd, Zhangzhou Industrial Equity Investment Co., Ltd, and CICC Capital Operation Co., Ltd [1] Group 2: Investment Focus - The primary investment focus of the fund is on the healthcare sector, specifically in areas such as traditional Chinese medicine, biomedicine, medical devices, medical services, daily chemical beauty products, and health and wellness [1] - The fund will also consider projects related to the Pien Tze Huang industry chain, the Pien Tze Huang industrial park, and projects that attract investment to Zhangzhou [1] Group 3: Financial Commitment - Pien Tze Huang's wholly-owned subsidiary, Zhangzhou Pien Tze Huang Investment Management Co., Ltd, plans to invest 200 million RMB as a limited partner, representing 20% of the target fundraising scale of the CICC Medical Fund [1]

Group 1 - The company plans to invest in the CICC (Zhangzhou) Medical Industry Investment Partnership (tentative name), referred to as "CICC Medical Fund" [1] - The company's wholly-owned subsidiary, Zhangzhou Pianzaihuang Investment Management Co., Ltd., will act as a limited partner and contribute 200 million yuan, accounting for 20% of the target fundraising scale of the CICC Medical Fund [1] - The main investment areas of the fund include healthcare investments, focusing on traditional Chinese medicine, biomedicine, medical devices, medical services, daily chemical beauty products, and health and wellness industries [1] Group 2 - The fund will invest in projects related to the Pianzaihuang industry chain, Pianzaihuang industrial park, and projects that attract investment to Zhangzhou [1]

Group 1 - The company plans to invest in the CICC (Zhangzhou) Medical Industry Investment Partnership (tentative name, referred to as "CICC Medical Fund") [1] - The company's wholly-owned subsidiary, Zhangzhou Pianzaihuang Investment Management Co., Ltd., will act as a limited partner and contribute 200 million yuan, accounting for 20% of the target fundraising scale of the CICC Medical Fund [1] - The main investment areas of the fund include healthcare investments, focusing on traditional Chinese medicine, biomedicine, medical devices, medical services, daily chemical beauty products, and health and wellness industries [1]